Beijing Tongrentang Co., Ltd

Shanghai Stock Exchange 600085.SS

Beijing Tongrentang Co., Ltd Goodwill for the year ending December 31, 2023: USD 6.45 M

Beijing Tongrentang Co., Ltd Goodwill is USD 6.45 M for the year ending December 31, 2023, a -1.43% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Beijing Tongrentang Co., Ltd Goodwill for the year ending December 31, 2022 was USD 6.54 M, a 0.40% change year over year.
Beijing Tongrentang Co., Ltd Goodwill for the year ending December 31, 2021 was USD 6.52 M, a -2.20% change year over year.
Beijing Tongrentang Co., Ltd Goodwill for the year ending December 31, 2020 was USD 6.66 M, a -2.12% change year over year.
Beijing Tongrentang Co., Ltd Goodwill for the year ending December 31, 2019 was USD 6.81 M, a 0.82% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Shanghai Stock Exchange: 600085.SS

Beijing Tongrentang Co., Ltd

CEO	Ms. Chaohua Zhang
IPO Date	June 25, 1997
Location	China
Headquarters	No. 42 Chongwenmenwai Street
Employees	16,777
Sector	Health Care
Industries Pharmaceuticals

Description

Beijing Tongrentang Co., Ltd engages in the scientific research, production, sale, and distribution of Chinese medicines in China and internationally. It covers product formulations, such as pills, powders, wines and capsules, oral liquids, and dripping pills with the original powder preparation in the areas of cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The company sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Hemiplegia recovery pills, etc. The company is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.

Key trends

Past 5 years